Multiple myeloma (MM) is unique among hematological malignancies for its association to skeletal destruction causing hypercalcemia, bone pain and increased risk of fractures. MM cells are able to induce a disregulation in the equilibrium between bone formation and bone resorption by recruiting osteoclast (OC) precursors and facilitating osteoclastogenesis. The role of Notch signalling in skeletal development and tissue remodelling and its hyperactivation in MM prompted us to evaluate if Notch participates in MM-induced osteoclastogenesis. Our results indicate that Notch inhibition impairs MM-mediated OCs differentiation, reducing the frequency and size of TRAP+ multinucleated cells. Accordingly Notch pathway controls TRAP gene expression in OCs. Finally, Notch plays a role in the regulation of key pathways active in osteoclastogenesis like RANK/RANKL and CXCR4/CXCL12. This data support a the rationale for a Notch-targeted therapy for the treatment of MM associated bone disease.

Notch receptors regulate multiple myeloma-driven osteoclastogenesis / M. Colombo, L. Mirandola, N. Platonova, E. Lazzari, M. Lancellotti, L. Apicella, R. Chiaramonte. ((Intervento presentato al convegno Hallmarks of Cancer tenutosi a San Francisco nel 2012.

Notch receptors regulate multiple myeloma-driven osteoclastogenesis

M. Colombo
Primo
;
L. Mirandola
Secondo
;
N. Platonova;E. Lazzari;L. Apicella
Ultimo
;
R. Chiaramonte
Ultimo
2012-10-31

Abstract

Multiple myeloma (MM) is unique among hematological malignancies for its association to skeletal destruction causing hypercalcemia, bone pain and increased risk of fractures. MM cells are able to induce a disregulation in the equilibrium between bone formation and bone resorption by recruiting osteoclast (OC) precursors and facilitating osteoclastogenesis. The role of Notch signalling in skeletal development and tissue remodelling and its hyperactivation in MM prompted us to evaluate if Notch participates in MM-induced osteoclastogenesis. Our results indicate that Notch inhibition impairs MM-mediated OCs differentiation, reducing the frequency and size of TRAP+ multinucleated cells. Accordingly Notch pathway controls TRAP gene expression in OCs. Finally, Notch plays a role in the regulation of key pathways active in osteoclastogenesis like RANK/RANKL and CXCR4/CXCL12. This data support a the rationale for a Notch-targeted therapy for the treatment of MM associated bone disease.
Settore MED/04 - Patologia Generale
Settore MED/06 - Oncologia Medica
Settore MED/46 - Scienze Tecniche di Medicina di Laboratorio
http://www.cell-symposia-hallmarksofcancer.com/conference-program.html
Notch receptors regulate multiple myeloma-driven osteoclastogenesis / M. Colombo, L. Mirandola, N. Platonova, E. Lazzari, M. Lancellotti, L. Apicella, R. Chiaramonte. ((Intervento presentato al convegno Hallmarks of Cancer tenutosi a San Francisco nel 2012.
Conference Object
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/224647
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact